The Koch Institute’s Annual Symposium highlights emerging successes and challenges in the advancement of vaccines to prevent and treat cancer.

A new approach opens the door to a greater understanding of protein-microbe interactions.

A new technology called RIBOmap can give researchers valuable insight into how protein production in animal and human tissue is altered in disease.

SMART researchers combine rifaximin and clarithromycin to effectively restore the latter drug's efficacy.

MIT researchers characterize gene expression patterns for 22,500 brain vascular cells across 428 donors, revealing insights for Alzheimer’s onset and potential treatments.

Tactile stimulation improved motor performance, reduced phosphorylated tau, preserved neurons and synapses, and reduced DNA damage, a new study shows.

On March 10 the FDA approved Trofinetide, a drug based on the protein IGF-1. The MIT professor's original research showing that IGF-1 could treat Rett was published in 2009.

A new study identifies cells that are the most vulnerable within a brain structure involved in mood and movement.

Harnessing these protective molecules may offer a new way to treat the disease, which spreads through contaminated water.

Researchers used a powerful deep-learning model to extract important data from electronic health records that could assist with personalized medicine.